Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.
Press releases published on September 4, 2025
Communiqué de presse : L’amlitelimab de Sanofi a atteint tous les critères d’évaluation principaux et secondaires clés dans l’étude de phase 3 COAST 1 menée chez des adultes et des adolescents atteints de dermatite atopique
GlobeNewswire
·
September 4, 2025
L’amlitelimab de Sanofi a atteint tous les critères d’évaluation principaux et secondaires clés dans l’étude de phase 3 COAST 1 menée chez des adultes et des adolescents atteints de dermatite atopique L’amlitelimab, administré toutes les quatre semaines ou …
Kuros Biosciences announces changes in the Board of Directors
GlobeNewswire
·
September 4, 2025
Ad-hoc announcement pursuant to Article 53 of the SIX listing rules Kuros Biosciences announces changes in the Board of Directors Schlieren (Zurich), Switzerland, September 4, 2025 – Kuros Biosciences (“Kuros” or the “Company”) a leader in next generation …
ProductLife Group Expands to Deliver Localized Expertise & Enhanced Client Support in Japan
GlobeNewswire
·
September 4, 2025
PARIS, Sept. 04, 2025 (GLOBE NEWSWIRE) -- ProductLife Group (PLG) is proud to announce the opening of its newest office in Japan, reinforcing its commitment to meeting evolving client needs and market demands. This expansion enhances capacity, strengthens …
JUST ON SLEEP Officially Launches on Shopee Singapore, Redefining Sleep Safety and Wellness
GlobeNewswire
·
September 4, 2025
SINGAPORE, Sept. 03, 2025 (GLOBE NEWSWIRE) -- JUST ON SLEEP, a smart contactless sleep monitoring device developed by Sewon Intelligence, has recently launched in Singapore via Shopee, making advanced sleep wellness and safety solutions more accessible to …
Mesoblast Enters Into Option To Issue US$50 Million Convertible Notes
GlobeNewswire
·
September 4, 2025
NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced it has entered into convertible note subscription agreements with SurgCenter …